BET inhibition blocks inflammation-induced cardiac dysfunction and SARS-CoV-2 infectionRichard J. Mills, James E. Hudson, Sean J. Humphrey et al.|Cell|2021Cited by 236
A versatile reverse genetics platform for SARS-CoV-2 and other positive-strand RNA virusesAlberto A. Amarilla, Alexander A. Khromykh, Morgan E. Freney et al.|Nature Communications|2021Cited by 177
Synthetic Heparan Sulfate Mimetic Pixatimod (PG545) Potently Inhibits SARS-CoV-2 by Disrupting the Spike–ACE2 InteractionScott E. Guimond, Jeremy E. Turnbull, Courtney J. Mycroft‐West et al.|ACS Central Science|2022Cited by 112
Monoclonal Antibodies Specific for SARS-CoV-2 Spike Protein Suitable for Multiple Applications for Current Variants of ConcernMahali S. Morgan, Jody Hobson‐Peters, Kexin Yan et al.|Viruses|2022Cited by 21
Targeting novel LSD1-dependent ACE2 demethylation domains inhibits SARS-CoV-2 replicationWen Juan Tu, Sudha Rao, Robert McCuaig et al.|Cell Discovery|2021Cited by 20